Multidrug-resistant VAP before and during the COVID-19 pandemic among hospitalized patients in a tertiary private hospital.

Alec Ann Alissa F Aligui Cybele Lara R Abad

Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2023)

The frequency of VAP and MDR VAP increased during the COVID-19 period, despite a shorter duration of hospital stay. The mortality of VAP was extremely high. Factors associated with increased risk of VAP and COVID-19 need to be studied further, and preventive measures should be prioritized.

Keyphrases

multidrug resistant
coronavirus disease
sars cov
healthcare
drug resistant
gram negative
acute care
health insurance
cardiovascular events
emergency department
adverse drug
type diabetes
risk factors
escherichia coli
respiratory syndrome coronavirus
pseudomonas aeruginosa
coronary artery disease